Dear Friends and colleagues,
As we all know, CSIR as a family is moving ahead with a mission program of SERO-SURVEY : Phenome India. This is certainly going to help and understand our physical and biological capabilities to sustain ourselves against threats like Covid 19. We request you to please go through the google link below to understand the program in detail. All permanent staff/PA/JRF/RA/PFs along with their families are requested to participate in this national endeavor on voluntary basis, by filling up the google form (LINK given below). The Privacy of participant and confidentiality of the information obtained would be protected as required by law. The dependents/wards of permanent and temporary staff/members (PA/JRF/RA/AcSIR) of CSIR NML can participate in this drive. The modality of the drive including blood sample collection will be intimated separately. Let us, participate in huge numbers with a sense of duty for Nation.
As a citizen of India and member of prestigious R&D fraternity, let us support and serve our beloved nation with huge participation. We are expecting your kind responses through GOOGLE form below by 2-3 days to plan the modalities. For any queries the undersigned can be contacted.
Registration of all employees/PA/RA/AcSIR students along with family/dependents is highly encouraged in this national drive to fight against Covid 19.
We can contribute with just 5ml of blood and a Google form.
Regards
"Phenome India"
CSIR NML Team
Note: Some useful Information from attached google form.
"Phenome India - A long-term longitudinal observational cohort study of health outcomesIntroduction of the study:
Large-scale phenome data from longitudinal cohort studies are critical for investigating the cause of disease and to establish links between risk factor and health outcome. It can yield a wealth of information in establishing causation and development of diagnostic and prognostic biomarkers especially for communicable and chronic non communicable diseases which is an emerging health crisis in India. Such studies have been conducted in other parts of the world to identify risk factors related to genetic and lifestyle related disorders, and factors important for health outcomes. We will also perform serology testing for infectious diseases caused by microbes like SARS-CoV-2 to assess the status of antibody in your body against these microbes. In India we do not have such large scale longitudinal follow up of individuals to understand the India specific factors. India having vast array of variability with respect to genetic- ethnic background and geographical and environmental conditions, it is even more pertinent to identify such factors considering these variations. We at CSIR therefore have undertaken this study towards development of CSIR- health cohort wherein CSIR employees spanning across laboratories would be invited to participate in the study.
AIM and objectives of the Study:
To develop a standardized protocol for obtaining lifestyle, dietary, and clinical information towards establishing a prospective cohort and carry out molecular profiling to examine health outcomes and to perform serology test for infectious diseases caused by microbes like SARS-CoV-2
" Benefits of the study:
There are no immediate benefits to you from this study; However, the outcome of this study is critical for investigating the cause of disease and to establish links between risk factor and health outcome. It can yield a wealth of information in establishing causation and development of diagnostic and prognostic biomarkers especially for chronic non communicable diseases which is an emerging health crisis in India. The serology tests will help you understand if you have already developed antibodies to certain infectious diseases caused by microbes like SARS-CoV-2"
- Krishna KumarScientist, Nonferrous Processing Group
Metal Extraction & Recycling Division
PhD Scholar, AcSIR
CSIR-National Metallurgical Laboratory, Jamshedpur
(contact : +91 9470389903, email : kkrishna@nmlindia.org)